Evidence map›Paper›PMID 27666374›Full record

ArticleAmerican journal of human genetics2016

Biallelic TBCD Mutations Cause Early-Onset Neurodegenerative Encephalopathy.

Noriko Miyake, Ryoko Fukai, Chihiro Ohba, Takahiro Chihara, Masayuki Miura, Hiroshi Shimizu, Akiyoshi Kakita, Eri Imagawa, Masaaki Shiina, Kazuhiro Ogata and 23 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Variant inInternational journal of molecular sciences · 2023
    Article
  8. CRISPR/Cas9 andInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Novel Compound Heterozygous Variants inChildren (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. The utility of whole exome sequencing for identification of the molecular etiology in autosomal recessive developmental and epileptic encephalopathies.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 13 institutions in 3 countries.

Noriko MiyakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan. Electronic address: nmiyake@yokohama-cu.ac.jp.
Ryoko FukaiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan; Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Chihiro OhbaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan; Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Takahiro ChiharaDepartment of Biological Science, Graduate School of Science, Hiroshima University, Hiroshima 739-8526, Japan.
Masayuki MiuraDepartment of Genetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan; Agency for Medical Research and Development-Core Research for Evolutional Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development, Tokyo 100-0004, Japan.
Hiroshi ShimizuDepartment of Pathology, Brain Research Institute, University of Niigata, Niigata 951-8585, Japan.
Akiyoshi KakitaDepartment of Pathology, Brain Research Institute, University of Niigata, Niigata 951-8585, Japan.
Eri ImagawaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Masaaki ShiinaDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Kazuhiro OgataDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Jiu Okuno-YuguchiDepartment of Neuropediatrics, Nagano Children's Hospital, Azumino 399-8205, Japan.
Noboru FuekiDivision of Rehabilitation, Nagano Children's Hospital, Azumino 399-8205, Japan.
Yoshifumi OgisoDepartment of Clinical Pathology, Nagano Children's Hospital, Azumino 399-8288, Japan.
Hiroshi SuzumuraDepartment of Pediatrics, Dokkyo Medical University School of Medicine, Tochigi 321-0293, Japan.
Yoshiyuki WatabeDepartment of Pediatrics, Dokkyo Medical University School of Medicine, Tochigi 321-0293, Japan.
George ImatakaDepartment of Pediatrics, Dokkyo Medical University School of Medicine, Tochigi 321-0293, Japan.
Huey Yin LeongGenetics Department, Hospital Kuala Lumpur, Kuala Lumpur 50586, Malaysia.
Aviva Fattal-ValevskiPediatric Neurology Unit, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Uri KramerPediatric Neurology Unit, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Mitsuhiro KatoDepartment of Pediatrics, Showa University School of Medicine, Tokyo 142-8666, Japan.
Nobuhiko OkamotoDepartment of Medical Genetics, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka 594-1101, Japan.
Yoshinori SatoDepartment of Molecular Biology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Satomi MitsuhashiDepartment of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan; Department of Medical Genome Development, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.
Ichizo NishinoDepartment of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan; Department of Medical Genome Development, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.
Naofumi KanekoDepartment of Immunology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Akira NishiyamaDepartment of Immunology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Tomohiko TamuraDepartment of Immunology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Takeshi MizuguchiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Mitsuko NakashimaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Fumiaki TanakaDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Hirotomo SaitsuDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan. Electronic address: naomat@yokohama-cu.ac.jp.
Yokohama City University · JPDokkyo Medical University · JPNagano Children's Hospital · JPNational Center of Neurology and Psychiatry · JPNiigata University · JPHamamatsu University School of Medicine · JPHiroshima University · JPHospital Kuala Lumpur · MYJapan Agency for Medical Research and Development · JPOsaka Medical Center for Cancer and Cardiovascular Diseases · JPShowa University · JPTel Aviv Sourasky Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe four families with affected siblings showing unique clinical features: early-onset (before 1 year of age) progressive diffuse brain atrophy with regression, postnatal microcephaly, postnatal growth retardation, muscle weakness/atrophy, and respiratory failure. By whole-exome sequencing, we identified biallelic TBCD mutations in eight affected individuals from the four families. TBCD encodes TBCD (tubulin folding co-factor D), which is one of five tubulin-specific chaperones playing a pivotal role in microtubule assembly in all cells. A total of seven mutations were found: five missense mutations, one nonsense, and one splice site mutation resulting in a frameshift. In vitro cell experiments revealed the impaired binding between most mutant TBCD proteins and ARL2, TBCE, and β-tubulin. The in vivo experiments using olfactory projection neurons in Drosophila melanogaster indicated that the TBCD mutations caused loss of function. The wide range of clinical severity seen in this neurodegenerative encephalopathy may result from the residual function of mutant TBCD proteins. Furthermore, the autopsied brain from one deceased individual showed characteristic neurodegenerative findings: cactus and somatic sprout formations in the residual Purkinje cells in the cerebellum, which are also seen in some diseases associated with mitochondrial impairment. Defects of microtubule formation caused by TBCD mutations may underlie the pathomechanism of this neurodegenerative encephalopathy.

Indexed as

AllelesAdolescentAge of OnsetAmino Acid SequenceAnimalsBrain DiseasesChildChild, PreschoolDrosophila melanogasterExomeFemaleFrameshift MutationGTP-Binding ProteinsHumansInfantInfant, NewbornARL2 protein, humanGTP-Binding ProteinsMicrotubule-Associated ProteinsMolecular ChaperonesRNA Splice SitesTBCD protein, humanTBCE protein, humanTubulin

Identifiers

PMID27666374
PMCPMC5065661
OpenAlexW2460850128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.